Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-96,510
Closed -$2.53M 76
2022
Q1
$2.53M Buy
96,510
+22,857
+31% +$642K 1.35% 30
2021
Q4
$3.1M Sell
73,653
-35,200
-32% -$1.57M 1.21% 32
2021
Q3
$3.18M Buy
+108,853
New +$3.17M 1.34% 27

Other funds holding NOTV

Friess Associates's NOTV Position: Q2 2022 in Review

Friess Associates sold out of Inotiv (NOTV) in Q2 2022, closing a stake of 96,510 shares — an estimated $2.53M sold.

Friess Associates first reported a position in NOTV in Q3 2021 and held it in 3 quarters. The position peaked at $3.18M in Q3 2021. 89 funds tracked by Wall St. Rank hold NOTV as of Q2 2022.

  • Friess Associates reported no remaining Inotiv position as of Q2 2022 after selling out during the quarter.
  • Friess Associates sold 96,510 Inotiv shares in Q2 2022, an estimated $2.53M.
  • Friess Associates first reported a position in Inotiv in Q3 2021 and held it in 3 quarters.
  • Friess Associates's Inotiv position peaked at $3.18M in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Inotiv as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.